John W. Colson, PhD is currently Director of Operations at ClostraBio, Inc, a University of Chicago spinout creating new medicines to prevent and treat life-threatening allergies to food. Prior to ClostraBio, John was a postdoctoral scholar and an Associate with the Innovation Fund at the University of Chicago where he led the diligence process on multiple deals in the cleantech and internet connectivity spaces. John earned his PhD in Chemistry from Cornell University in 2014.
